Matthew Zibelman
6PUBLICATIONS
61CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Dec 16, 2024
Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1).Daniel M Geynisman, Philip H Abbosh, Eric Ross
|Jun 12, 2024
Urine Biopsy as Dynamic Biomarker to Enhance Clinical Staging of Bladder Cancer in Radical Cystectomy Candidates.Uttam Satyal, Henkel Valentine, David Liu
|Jul 27, 2023
A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors.Matthew Zibelman, Alexander W MacFarlane, Kimberly Costello
|Mar 17, 2023
A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy.H Josh Jang, Galen Hostetter, Alexander W Macfarlane
|Nov 07, 2022
Platinum-Free Systemic Therapy in First-Line Metastatic Urothelial Carcinoma: Mirage or Oasis in the Platinum Desert?Elizabeth R Plimack, Matthew R Zibelman
|Apr 21, 2022
Orteronel for Metastatic Hormone-Sensitive Prostate Cancer: A Multicenter, Randomized, Open-Label Phase III Trial (SWOG-1216).Neeraj Agarwal, Catherine M Tangen, Maha H A Hussain
Pageof 1
Frequent Collaborators
5 joint publications
Elizabeth R Plimack
3 joint publications
Daniel M Geynisman
3 joint publications
Eric Ross
2 joint publications
Rutika Kokate
2 joint publications
Philip H Abbosh
2 joint publications
Jean H Hoffman-Censits
2 joint publications
David I Quinn
1 joint publications
Catherine M Tangen
1 joint publications
Primo N Lara
1 joint publications
Channing J Paller
